Evidence map›Paper›PMID 42362994›Full record

SynthesisEye (London, England)2026

Functional visual loss: a systematic review and meta-analysis of epidemiology, prognosis and treatment.

Neil Ramsay, Helena Tessmann, Justin McKee, Tommaso Ercoli, Jon Stone

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Eye (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Neil RamsayDeparment of Neurology, NHS Fife, Dunfermline, UK.ORCID http://orcid.org/0000-0003-3179-8126
Helena TessmannNeuropsychology Service, South East Scotland Major Trauma Centre, Edinburgh, UK.ORCID http://orcid.org/0009-0000-7414-6780
Justin McKeePrincess Alexandra Eye Pavilion and Department of Clinical Neurology, Royal Infirmary of Edinburgh, Edinburgh, UK.
Tommaso ErcoliNeurology Unit, University Hospital of Sassari, Sassari, Italy.
Jon StoneCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK. jon.stone@ed.ac.uk.ORCID http://orcid.org/0000-0001-9829-8092

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Functional visual loss is a common issue in neuro-ophthalmology settings. There are many studies focused on diagnosis, but there is limited literature on associated epidemiology, phenomenology, prognosis and treatment. We carried out the first systematic review and meta-analysis assessing these domains. We systematically reviewed PubMed from 1951 for studies reporting clinical data on adults and children with functional visual loss. Data on variables relevant to epidemiology, phenomenology, comorbidity, risk factors, prognosis and treatment were extracted. Random effects meta-analyses were performed where appropriate. Forty-four studies of functional visual loss (n = 2284, 67% female) were included. The pooled median age was 43 years (IQR 12.5-43 years). Common associations included facial/ocular trauma (19%, n = 288), ocular comorbidity (25%, n = 470), headache (39%, n = 124) and other functional symptom/disorder (10-29%). Good quality data on psychiatric comorbidity and adverse childhood experience were unavailable. Prognosis data (n = 1019, 13 studies) were heterogeneous, but outcome appeared more favourable in paediatric studies. Most studies did not distinguish between symptomatic visual loss and functional visual signs which are asymptomatic (such as spiralled fields) or disproportionate to symptoms (such as severe acuity loss in someone with minor visual symptoms). There are very limited data on treatment. This systematic review highlights some basic epidemiological data and relevant aetiological factors in functional visual loss but also the significant gaps that must be addressed to improve care for this disabling condition.

Indexed as

BlindnessVision DisordersAdultChildFemaleHumansPrognosisRisk FactorsVisual Acuity

Identifiers

PMID42362994
PMCPMC13463093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.